These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
223 related items for PubMed ID: 12792789
1. Protection against Adriamycin cytotoxicity and inhibition of DNA topoisomerase II activity by 3,4-dihydroxybenzoic acid. De Graff WG, Myers LS, Mitchell JB, Hahn SM. Int J Oncol; 2003 Jul; 23(1):159-63. PubMed ID: 12792789 [Abstract] [Full Text] [Related]
3. Evaluation of the topoisomerase II-inactive bisdioxopiperazine ICRF-161 as a protectant against doxorubicin-induced cardiomyopathy. Martin E, Thougaard AV, Grauslund M, Jensen PB, Bjorkling F, Hasinoff BB, Tjørnelund J, Sehested M, Jensen LH. Toxicology; 2009 Jan 08; 255(1-2):72-9. PubMed ID: 19010377 [Abstract] [Full Text] [Related]
4. Reduction of doxorubicin cytotoxicity by ouabain: correlation with topoisomerase-induced DNA strand breakage in human and hamster cells. Lawrence TS. Cancer Res; 1988 Feb 01; 48(3):725-30. PubMed ID: 2825982 [Abstract] [Full Text] [Related]
6. Doxorubicin-DNA adducts induce a non-topoisomerase II-mediated form of cell death. Swift LP, Rephaeli A, Nudelman A, Phillips DR, Cutts SM. Cancer Res; 2006 May 01; 66(9):4863-71. PubMed ID: 16651442 [Abstract] [Full Text] [Related]
8. Isolation of two Chinese hamster ovary cell mutants hypersensitive to topoisomerase II inhibitors and cross-resistant to peroxides. Davies SM, Davies SL, Harris AL, Hickson ID. Cancer Res; 1989 Aug 15; 49(16):4526-30. PubMed ID: 2545343 [Abstract] [Full Text] [Related]
9. DNA topoisomerase II-mediated interaction of doxorubicin and daunorubicin congeners with DNA. Bodley A, Liu LF, Israel M, Seshadri R, Koseki Y, Giuliani FC, Kirschenbaum S, Silber R, Potmesil M. Cancer Res; 1989 Nov 01; 49(21):5969-78. PubMed ID: 2551497 [Abstract] [Full Text] [Related]
11. Direct correlation between DNA topoisomerase II activity and cytotoxicity in adriamycin-sensitive and -resistant P388 leukemia cell lines. Deffie AM, Batra JK, Goldenberg GJ. Cancer Res; 1989 Jan 01; 49(1):58-62. PubMed ID: 2535693 [Abstract] [Full Text] [Related]
15. Modulation of the cell cycle-dependent cytotoxicity of adriamycin and 4-hydroperoxycyclophosphamide by novobiocin, an inhibitor of mammalian topoisomerase II. Lee FY, Flannery DJ, Siemann DW. Cancer Res; 1992 Jul 01; 52(13):3515-20. PubMed ID: 1319822 [Abstract] [Full Text] [Related]
16. Synergistic interactions between tumor necrosis factor and inhibitors of DNA topoisomerase I and II. Baloch Z, Cohen S, Coffman FD. J Immunol; 1990 Nov 01; 145(9):2908-13. PubMed ID: 2170526 [Abstract] [Full Text] [Related]
17. Induction of genotoxic and cytotoxic damage by aclarubicin, a dual topoisomerase inhibitor. Hajji N, Mateos S, Pastor N, Domínguez I, Cortés F. Mutat Res; 2005 May 02; 583(1):26-35. PubMed ID: 15866463 [Abstract] [Full Text] [Related]
18. Use of catalytic topoisomerase II inhibitors to probe mechanisms of chemical-induced clastogenicity in Chinese hamster V79 cells. Snyder RD. Environ Mol Mutagen; 2000 May 02; 35(1):13-21. PubMed ID: 10692223 [Abstract] [Full Text] [Related]
19. 3'-Deamino-3'-morpholino-13-deoxo-10-hydroxycarminomycin conquers multidrug resistance by rapid influx following higher frequency of formation of DNA single- and double-strand breaks. Horichi N, Tapiero H, Sugimoto Y, Bungo M, Nishiyama M, Fourcade A, Lampidis TJ, Kasahara K, Sasaki Y, Takahashi T. Cancer Res; 1990 Aug 01; 50(15):4698-701. PubMed ID: 2164445 [Abstract] [Full Text] [Related]
20. Plantainoside D protects adriamycin-induced apoptosis in H9c2 cardiac muscle cells via the inhibition of ROS generation and NF-kappaB activation. Kim DS, Woo ER, Chae SW, Ha KC, Lee GH, Hong ST, Kwon DY, Kim MS, Jung YK, Kim HM, Kim HK, Kim HR, Chae HJ. Life Sci; 2007 Jan 02; 80(4):314-23. PubMed ID: 17034819 [Abstract] [Full Text] [Related] Page: [Next] [New Search]